Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Genentech and Hoffmann-La Roche describe DLK inhibitors

Sep. 28, 2016

Hoffmann-La Roche discloses TLR8 agonists

Sep. 28, 2016

Pharmakea patents LOX2 inhibitors

Sep. 28, 2016

LTT Bio-Pharma presents muscarinic M3 receptor antagonists

Sep. 27, 2016

BioMarin Pharmaceutical develops CGS inhibitors

Sep. 27, 2016

Merck & Co. describes IRAK-4 inhibitors

Sep. 27, 2016

Emory University discloses RNA-directed RNA polymerase inhibitors

Sep. 27, 2016

Novartis patents angiotensin AT2 receptor antagonists

Sep. 27, 2016

Bristol-Myers Squibb develops ROCK2 inhibitors

Sep. 26, 2016

Peloton Therapeutics describes HIF-2alpha inhibitors

Sep. 26, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...